This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: CSF p-tau as a potential cognition impairment biomarker in ALS
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAmyotrophic Lateral Sclerosis Research · Neuroinflammation and Neurodegeneration Mechanisms · Intracerebral and Subarachnoid Hemorrhage Research
The journal retracts the 01 November 2022 article cited above.
Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data during the investigation, which was conducted in accordance with Frontiers' policies. Given the lack of raw data, the editors no longer have confidence in the findings presented. The article is therefore retracted.
This retraction was approved by the Chief Editors of Frontiers in Neurology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.
Frontiers would like to thank the concerned reader who contacted us regarding the published article.